Table 1 Characteristics of individuals with candidemia in the Calgary zone from 2010 to 2018 (n = 455)
Characteristics | No. (%) |
|---|---|
Mean age (SD) | 59 (171) |
Female | 221 (47.4) |
Comorbidities | |
Diabetes | 112 (24.0) |
Cardiovascular disease | 226 (48.5) |
Ischemic heart disease | 82 (17.6) |
Congestive heart failure | 68 (14.6) |
Arrythmia | 110 (23.6) |
Congenital (incl. BAV) | 2 (0.4) |
Intracardiac device | 5 (1.1) |
Peripheral vascular disease | 24 (5.2) |
Cerebrovascular disease | 32 (6.9) |
Preceding bacterial infective endocarditis | 19 (4.1) |
Chronic liver disease | 91 (19.5) |
Cirrhosis fibrosis | 28 (6.0) |
Hepatitis C | 50 (10.7) |
Hepatitis B | 2 (0.4) |
Alcohol liver disease | 24 (5.2) |
Autoimmune hepatitis | 8 (1.7) |
Liver transplant | 2 (0.4) |
Pancreatitis | 19 (4.1) |
Chronic kidney disease | 76 (16.3) |
Haemodialysis | 22 (4.7) |
Peritoneal dialysis | 8 (1.7) |
Pulmonary disease | 97 (20.8) |
Bronchitis (incl. COPD) | 59 (12.7) |
Asthma | 24 (5.2) |
Obstructive sleep apnoea | 7 (1.5) |
Other factors | |
Cancer in last year | 108 (23.2) |
Solid organ cancer | 68 (14.6) |
Blood cancer | 33 (7.1) |
Solid organ transplantation | 17 (3.7) |
Individuals receiving parenteral nutrition (TPN) | 76 (16.3) |
Patient received ≥ 10 mg corticosteroids per day2 for last 30 d | 125 (26.8) |